Page last updated: 2024-10-28

hydralazine and Extravascular Hemolysis

hydralazine has been researched along with Extravascular Hemolysis in 2 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research Excerpts

ExcerptRelevanceReference
"Drugs which induce systemic lupus erythematosus as a toxic side effect have been shown to inhibit the covalent binding of C4, which is an important event in immune complex clearance in normal individuals."1.27Interaction of nucleophilic compounds with complement component C4. ( Jones, A; Parker, KE; Sim, E; Wood, M, 1988)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Padakanti, A1
Shenoy, A1
Kamath, A1
Chakrapani, M1
Sim, E1
Wood, M1
Parker, KE1
Jones, A1

Other Studies

2 other studies available for hydralazine and Extravascular Hemolysis

ArticleYear
Drug-induced Hemolysis in G6PD Deficiency: an Unusual Presentation of a Common Clinical Condition.
    Acta medica (Hradec Kralove), 2019, Volume: 62, Issue:4

    Topics: Cardiovascular Agents; Drug Combinations; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Huma

2019
Interaction of nucleophilic compounds with complement component C4.
    Comparative immunology, microbiology and infectious diseases, 1988, Volume: 11, Issue:3-4

    Topics: Animals; Chemical Phenomena; Chemistry; Complement C4; Complement C4a; Disease Models, Animal; Guine

1988